What is Atossa Genetics Inc?
, a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 15.92M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.